Calidad de la evidencia 4.88/5
Puntuación de revisión en ocho dimensiones según la rúbrica de calidad . Cada dimensión puntuada de 1 a 5.
- D1 Anclaje en las fuentes
- 4/5
- D2 Autoridad de las fuentes
- 5/5
- D3 Aritmética
- 5/5
- D4 Incertidumbre
- 5/5
- D5 Alcance
- 5/5
- D6 Prosa
- 5/5
- D7 Honestidad sobre la percepción
- 5/5
- D8 Completitud de las advertencias
- 5/5
Cómo varía el riesgo
La cifra principal promedia situaciones muy diferentes. Así es como varía la probabilidad según el escenario o el contexto:
—
No epidemiological study has measured attributable disease from dietary or airborne microplastic exposure in the general US population. Exposure is real; harm is unquantified.
—
Workers in synthetic textile and plastics manufacturing have higher inhalation exposure. Some occupational studies report elevated respiratory symptoms (flock worker's lung), but these involve specific fiber types at industrial concentrations, not general microplastic exposure. Signal is weak and confounded by co-exposures.
—
Shellfish and small pelagic fish bioaccumulate microplastics. Consumers of large quantities of mussels, oysters, and sardines have higher ingestion estimates, but no cohort study has linked this dietary pattern to measurable health outcomes in humans.
—
Bottled water contains roughly 10-100x more microplastic particles per liter than tap water in most studies, likely from packaging. WHO's 2019 review found no health risk from either source at observed levels.
La longitud y el tono de la barra clasifican estos escenarios entre sí, no frente a otros riesgos. Las probabilidades exactas se muestran junto a cada uno.
La brecha entre el miedo y la evidencia sobre los microplásticos es amplia, pero se mueve en una dirección inusual: el miedo no es que la ciencia diga que los microplásticos son seguros, sino que la ciencia aún no dice nada que sea procesable. La revisión de la OMS de 2019 sobre los microplásticos en el agua potable no encontró “evidencia fiable” de riesgo para la salud en los niveles de exposición actuales. La EFSA, después de revisar más de 100 estudios, no ha emitido una cifra de riesgo cuantificada y no espera completar su opinión formal hasta finales de 2027. Ninguna cohorte epidemiológica ha medido enfermedades humanas atribuibles a la exposición a microplásticos dietéticos o aerotransportados a niveles de población general. La entrada lleva no_reliable_estimate no porque se sepa que el riesgo es cero, sino porque nadie lo ha medido lo suficientemente bien como para ponerle un número.
Lo que impulsa el miedo es una heurística de “detección equivale a peligro”. Leslie et al. (2022) encontraron partículas microplásticas en el 77% de las muestras de sangre humana, un hallazgo genuino y sorprendente que demuestra la exposición sistémica. Ragusa et al. las encontraron en placentas. Marfella et al. (2024), publicado en el NEJM, informó que los pacientes con micro y nanoplásticos detectables en la placa de la arteria carótida tenían una tasa 4.5 veces mayor de eventos cardiovasculares que aquellos sin ellos. Pero la cohorte de Marfella fue preseleccionada (todos tenían enfermedad carotídea asintomática que requería cirugía), el estudio carecía de controles anticontaminación en el entorno operativo, y la asociación en una población enferma no es causalidad en el público general. Mientras tanto, la afirmación de exposición de “una tarjeta de crédito por semana” que ancló la percepción pública ha demostrado sobrestimar la ingestión real en uno o dos órdenes de magnitud: las estimaciones realistas se sitúan en torno a 0.01-0.1 gramos por semana, no 5 gramos.
El número aún no existe, y eso importa más que cualquier marcador de posición. La exposición ocupacional (trabajadores textiles y del plástico que inhalan fibras sintéticas en concentraciones industriales) tiene una base de evidencia escasa pero real para los efectos respiratorios, aunque confundida por coexposiciones. Los grandes consumidores de mariscos ingieren más partículas a través de la bioacumulación en moluscos. El agua embotellada entrega aproximadamente 10-100 veces más partículas por litro que el agua del grifo. Ninguno de estos gradientes de exposición se ha relacionado con resultados de salud medibles en humanos. El campo es pre-epidemiológico: sabemos que la exposición es universal, sospechamos plausibilidad biológica a partir de modelos animales e in vitro, y tenemos un estudio de asociación provocador pero metodológicamente controvertido. Eso no es nada, pero tampoco es una probabilidad.
Datos curiosos relacionados
Los microplásticos aparecen en sangre, pulmones y placentas humanas, y la mayoría de los adultos los sitúan entre sus principales preocupaciones de seguridad alimentaria. Pero la OMS no halló evidencia fiable de que los microplásticos a los niveles actuales de exposición dañen la salud. Detectar no es lo mismo que un riesgo medido.
Registro de evidencia
Cada número a continuación es lo que reportó cada fuente, con la cita textual en la que nos basamos y cómo llegamos a nuestra cifra. Haz clic en cualquier enlace para verificarlo directamente.
1/7 fuentes verificadas de forma independiente palabra por palabra frente a la fuente citada
-
[1] World Health Organization — Microplastics in Drinking-Water
Microplastics in Drinking-WaterSee all 3 Likelier entries citing this source →
- Estadística
No reliable evidence that microplastics in drinking water at current exposure levels pose a risk to human health- Extracto
“"Based on the limited information we have, microplastics in drinking water don't appear to pose a health risk at current levels. But we need to find out more." ”
- Datos de la fuente de
- 2019-08-22
- Accedido
- 2026-04-18 · copia archivada
- Cálculo
- WHO reviewed all available evidence on microplastic occurrence in drinking water (tap and bottled) and assessed potential health impacts from ingestion. The report concluded that particles larger than 150 micrometres are unlikely to be absorbed, uptake of smaller particles is expected to be limited, and no epidemiological data link drinking-water microplastic exposure to adverse health outcomes. WHO called for more research but did not identify a quantifiable risk, supporting the no_reliable_estimate classification.
- Independencia
- WHO review synthesised global evidence independently of the Marfella, Leslie, and EFSA analyses cited below.
-
[2] New England Journal of Medicine / Marfella et al. — Microplastics and Nanoplastics in Atheromas and Cardiovascular Events Verificado
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events- Estadística
Patients with detectable MNPs in carotid plaque had HR 4.53 (95% CI 2.00-10.27) for composite cardiovascular endpoint vs those without- Extracto
“"Patients in whom microplastics and nanoplastics were detected within the atheroma had a higher risk of a composite of myocardial infarction, stroke, or death from any cause than those in whom microplastics and nanoplastics were not detected." ”
- Datos de la fuente de
- 2024-03-07
- Accedido
- 2026-04-18 · copia archivada
- Verificación
- Extracto recuperado de forma independiente y confirmado palabra por palabra frente a la fuente citada durante nuestra auditoría de fundamentación.
- Cálculo
- Marfella et al. prospectively followed 257 patients who underwent carotid endarterectomy and analyzed excised plaque for MNPs via pyrolysis-GC/MS. Polyethylene was detected in 58.4% of plaques (150 of 257); PVC in 12.1% (31 patients). After 34 months, the MNP-positive group had significantly higher cardiovascular events. However, this is an observational study in a high-risk surgical cohort (all had asymptomatic carotid disease), and critics note no pre-analytical anticontamination procedures were used — the surgical environment itself contains PE and PVC. The study demonstrates association in a diseased population, not causation in the general public, and cannot be converted to a population-level attributable risk.
- Independencia
- Prospective clinical cohort study by Italian researchers using pyrolysis-GC/MS on excised plaque tissue; independent of WHO review and Leslie blood-detection study.
-
[3] Environment International / Leslie et al. — Discovery and quantification of plastic particle pollution in human blood
Discovery and quantification of plastic particle pollution in human blood- Estadística
Microplastics detected in 17 of 22 (77%) healthy adult blood samples at mean concentration of 1.6 µg/mL- Extracto
“"This is the first study to report quantitative data on plastic particle pollution in human blood, showing that plastic particles are bioavailable for uptake into the human bloodstream." ”
- Datos de la fuente de
- 2022-03-24
- Accedido
- 2026-04-18 · copia archivada
- Cálculo
- Leslie et al. analyzed blood from 22 healthy Dutch volunteers using pyrolysis-GC/MS for five high-production polymers. PET was the most prevalent (50% of samples), followed by polystyrene (36%) and PE (23%). The study proves systemic exposure (detection) but does not measure health outcomes. No dose-response relationship, no disease endpoint, no follow-up. Detection of a substance in blood is a necessary but not sufficient condition for harm — the dose, persistence, and biological activity all remain unquantified for general-population microplastic exposure. This study is included because it is the most-cited driver of public fear, illustrating the detection-equals-danger heuristic.
- Independencia
- Dutch laboratory study using independent pyrolysis-GC/MS methodology on volunteer blood samples; no overlap with the Marfella clinical cohort or WHO/EFSA reviews.
-
[4] Nature Medicine / Nihart et al. — Bioaccumulation of microplastics in decedent human brains
Bioaccumulation of microplastics in decedent human brains- Estadística
MNP concentration 7-30x higher in brain (median ~4900 µg/g) than liver/kidney; rose ~50% from 2016 to 2024; up to 10x higher in brains with documented dementia- Extracto
“"Concentrations in decedent brain samples were 7 to 30 times higher than in the liver or kidney... brain tissue from people who had been diagnosed with dementia had up to 10 times as much plastic in their brains as everyone else... the study design cannot show whether higher levels of plastic in the brain caused the dementia symptoms — they may simply accumulate more due to the disease process itself." ”
- Datos de la fuente de
- 2025-02-03
- Accedido
- 2026-06-14 · copia archivada
- Cálculo
- Nihart et al. applied pyrolysis-GC/MS (corroborated by FTIR and electron microscopy) to >50 autopsy samples from the Albuquerque medical examiner, from decedents in 2016 and 2024. Brain MNP load (predominantly polyethylene, largely nanoscale shard-like fragments) far exceeded liver and kidney, and rose ~50% across the eight-year window. Brains with a documented dementia diagnosis showed up to 10x more plastic, concentrated in cerebrovascular walls and immune cells. This is a cross-sectional autopsy series: the dementia association is explicitly correlation, not causation, and the authors flag reverse causation (impaired clearance / blood-brain-barrier breakdown in dementia could increase deposition). It quantifies tissue burden and its temporal rise, not attributable disease risk, so it does not change the no_reliable_estimate classification.
- Independencia
- US autopsy-tissue study using pyrolysis-GC/MS plus FTIR and electron microscopy; methodologically independent of the WHO review, the Marfella plaque cohort, the Leslie blood study, and the EFSA assessment.
-
[5] European Food Safety Authority — Microplastics and nanoplastics in food
Microplastics and nanoplastics in food- Estadística
EFSA risk assessment on microplastics in food scheduled for completion by end of 2027; no quantified health risk established as of 2025- Extracto
“"The European Parliament has requested EFSA to deliver a scientific opinion on the potential health risks posed by microplastics in food, water and air." ”
- Datos de la fuente de
- 2025-10-28
- Accedido
- 2026-04-18 · copia archivada
- Cálculo
- EFSA's 2025 literature review of micro- and nanoplastic release from food contact materials analyzed over 100 studies (2015-2025) and concluded that while microplastic release from FCMs is real, current studies likely overestimate quantities, and nanoplastic data remain insufficient for reliable exposure estimates. EFSA has not issued a quantified risk figure. Their formal scientific opinion is not expected until end of 2027. The absence of an EFSA opinion after years of review is itself evidence of the epistemic gap — not of safety, but of insufficient data to quantify risk in either direction.
- Independencia
- EFSA risk assessment is an independent EU regulatory review, methodologically separate from the WHO 2019 review and from individual primary studies.
-
[6] Journal of Hazardous Materials Letters / Pletz (2022) — Ingested Microplastics: Do Humans Eat One Credit Card per Week?
Ingested Microplastics: Do Humans Eat One Credit Card per Week?- Estadística
The widely cited 5g/week estimate overestimates ingestion by several orders of magnitude; realistic estimates are 0.01-0.1g/week- Extracto
“"Our analysis suggests that the widely reported figure of 5 g per week overestimates microplastic ingestion by several orders of magnitude." ”
- Datos de la fuente de
- 2022-12-01
- Accedido
- 2026-04-18 · copia archivada
- Cálculo
- Pletz (2022) critically reviewed the Senathirajah et al. (2021) analysis that generated the "credit card per week" claim. The 5g figure was the extreme upper bound of a 0.1-5g range, and the underlying methodology conflated particle counts with mass in ways that inflate estimates. More careful analyses suggest typical adult ingestion is roughly 0.01-0.1g per week — still nonzero, but 50-500x lower than the headline figure. This matters because the perceived threat level is anchored to an exposure estimate that is almost certainly wrong by orders of magnitude.
- Independencia
- Critical reanalysis of the WWF/Newcastle exposure estimate by independent food-science researchers; not affiliated with WHO, EFSA, or the original 2019 study authors.
-
[7] Environment International / Ragusa et al. — Plasticenta: First evidence of microplastics in human placenta
Plasticenta: First evidence of microplastics in human placenta- Estadística
12 microplastic fragments (5-10 micrometers) detected via Raman microspectroscopy in 4 of 6 human placentas from uneventful pregnancies- Extracto
“"In total, 12 microplastic fragments (ranging from 5 to 10 [micrometers] in size)...were found in 4 placentas." ”
- Datos de la fuente de
- 2021-01-01
- Accedido
- 2026-07-03 · copia archivada
- Cálculo
- Substantiates the body prose's "Ragusa et al. found them in placentas" claim. First reported detection of microplastics in human placental tissue (fetal side, maternal side, and chorioamniotic membranes) in a small sample of six placentas from uneventful pregnancies. Like the Leslie blood study, this proves detection/bioavailability, not attributable health harm -- no outcome data, no dose-response, no disease endpoint measured. Does not change the no_reliable_estimate classification.
- Independencia
- Italian clinical/laboratory study using Raman microspectroscopy on placental tissue; methodologically independent of the WHO review, the Marfella plaque cohort, the Leslie blood study, the Nihart brain study, and the EFSA assessment.